Analyst picks & changes

SciClone Pharmaceuticals Inc.

(SCLN)

Charles Engelberg of Montgomery Securities maintained a "buy" on SciClone Pharmaceuticals Inc., the

Read the full 176 word article

How to gain access

Continue reading with a
two-week free trial.